Nicotinic acid, the most recent recruit to the vitamins whose chemical formula is known, provides a very good example. Many theories have been put forward regarding the cause of pellagra and, although the general opinion has for some time been veering towards Goldberger's pellagra-preventing (P-P) factor deficiency theory, the subject was still a controversial one. Now, since nicotinic acid has been identified as the P-P factor, within a year the whole aspect of the subject seems to have changed, and the part played by this substance in preventing and curing the symptoms of pellagra is so well understood that response to nicotinic acid is now being used as a therapeutic test, and symptoms that do not respond to this treatment are considered not to be part of the true pellagra syndrome.
In September 1937, Elvehjem and his coworkers reported that nicotinic acid cured blacktongue, a condition in dogs that previous work had shown to be analogous to pellagra in man, and before the end of the year three independent groups of workers, including Harris in Cambridge, had reported good results in human pellagra with nicotinic acid, even when the patients were allowed to continue their pellagraproducing diet. 
